Recordati Pharmaceuticals Limited
- Active
- Small
- 21 years
- 7 employees
- £15,346,040 (cur assets)
- £9,484,547 (revenue)
- 1m-15m
- Regular importer
- Real address
- 3 directors
- No owners
- Hemel Hempstead
Two conditions of three:
1.Turnover < £10.2 million
2.Balance sheet total < £5.1 million
3.Average number of employees < 50
The directors list was changed 1 month ago, a good sign to sell them something.
Field of Operation
Website
Social media
Summary
Recordati Pharmaceuticals Ltd, based in Hemel Hempstead, UK, is a sizable holding company with an active status. Established 20 years ago, in 2005, the company employs a small team of seven individuals and holds assets valued at £15,346,040. Its yearly revenue stands at £9,484,547. With three directors and one owner, the company operates from a real address, shared by five other businesses. It’s an irregular importer, primarily dealing in essential oils and perfumes, with the latest import occurring just one month ago.
The company’s website paints a picture of a global pharmaceutical enterprise. Recordati boasts a long history, spanning almost a century, and is listed on the Italian stock exchange. It focuses on developing and commercializing medicines for common and rare diseases, serving patients in approximately 150 countries. The website highlights its commitment to social and environmental responsibility, showcasing its operations, investor relations, and career opportunities. It also features a dedicated section for sustainability, detailing its ESG indices and contact information. The company even has a dedicated section for career opportunities, and a section for alerts.
Financially, Recordati Pharmaceuticals Ltd exhibits some concerning trends. While cash bank on hand increased by a respectable 10% to £1.9 million, net assets decreased by 44% to £2.4 million. This significant drop in equity, coupled with a 29% reduction in the average number of employees, suggests potential cost-cutting measures or a restructuring of operations. Interestingly, director remuneration increased by 72%, while pension costs plummeted 61%, indicating a shift in compensation strategies. Trade debtors have ballooned by 87%, which may be a sign of delayed customer payments, or perhaps an expansion of credit terms. The company’s auditor is James Cowper Kreston Audit. Overall, Recordati Pharmaceuticals Ltd appears to be navigating a period of change, balancing its global reach with internal adjustments.
Registered in England/Wales under the registration number 05421174, with a registered address at HP2 4TZ, England, Hemel Hempstead, Breakspear Park, Breakspear Way.
WARNING: The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.
Ports, countries, transport, and price/kg were calculated by CorpSignals; non-official data, may contain errors.
Managers
-
Individual
- 1 month
- 1
-
Resident of United Kingdom
-
Individual
- 1 year
-
Resident of Netherlands
-
Individual
- 1 year
-
Resident of Switzerland
Last reports
The latest confirmation statement submitted two months ago.
Last news
-
Appointment of Hywel Rhys Day as a director on 2026-05-13Download 2 pages pdf report
-
Confirmation statement made on 2026-04-11 with no updatesDownload 3 pages pdf report
-
Termination of appointment of Sanjay Thomas Verghese as a director on 2026-03-31Download 1 page pdf report
Importer profile by HS codes
Click on the map to see detailed UK statistics on HS code, including companies list.
Import HS codes in detail
Last imported products
Click on items to see detailed UK statistics on HS code, including companies list.
* Warning: Ports, countries, transport, and price/kg were calculated by CorpSignals; non-official data, may contain errors.
FAQ about Recordati Pharmaceuticals Limited
Looking for leads in the UK?
Book a demo—see how CorpSignals can help you find UK leads.